This Article Free upon publication Full Text Full Text (PDF) Data Supplement All Versions of this Article: 115/23/2957    most recent CIRCULATIONAHA.106.670026v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zakrzewicz, A. Articles by Eickelberg, O. Search for Related Content PubMed PubMed Citation Articles by Zakrzewicz, A. Articles by Eickelberg, O. Pubmed/NCBI databases Gene GEO Profiles HomoloGene Protein UniGene Genetics Home Reference Medline Plus Health Information Pulmonary Hypertension Related Collections Remodeling Smooth muscle proliferation and differentiation Pulmonary circulation and disease Endothelium/vascular type/nitric oxide Other Vascular biology

(Circulation. 2007;115:2957-2968.)
© 2007 American Heart Association, Inc.

Vascular Medicine

Receptor for Activated C-Kinase 1, a Novel Interaction Partner of Type II Bone Morphogenetic Protein Receptor, Regulates Smooth Muscle Cell Proliferation in Pulmonary Arterial Hypertension

Anna Zakrzewicz, PhD; Matthias Hecker, MD; Leigh M. Marsh, PhD; Grazyna Kwapiszewska, PhD; Bozena Nejman, MS; Lu Long, MD, PhD; Werner Seeger, MD; Ralph T. Schermuly, PhD; Nicholas W. Morrell, MD, FRCP; Rory E. Morty, PhD; Oliver Eickelberg, MD

From the Department of Medicine II (A.Z., M.H., L.M.M., G.K., B.N., W.S., R.T.S., R.E.M., O.E.), University of Giessen Lung Center, Justus Liebig University Giessen, Giessen, Germany, and Department of Medicine (L.L., N.W.M.), University of Cambridge School of Clinical Medicine, Addenbrooke’s and Papworth Hospitals, Cambridge, UK.

Correspondence to Oliver Eickelberg, MD, University of Giessen Lung Center, Department of Medicine II, Aulweg 123, Room 6–11, D-35392 Giessen, Germany. E-mail oliver.eickelberg{at}innere.med.uni-giessen.de

Received October 16, 2006; accepted March 29, 2007.

Background— Pulmonary arterial hypertension (PAH) is characterized by selective elevation of pulmonary arterial pressure. The pathological hallmark of PAH is the narrowing of pulmonary arterioles secondary to endothelial cell dysfunction and smooth muscle cell proliferation. Heterozygous mutations in BMPR2, encoding the type II bone morphogenetic protein receptor (BMPRII), were identified in PAH, suggesting that alterations to BMPRII function are involved in disease onset and/or progression.

Methods and Results— We identified the receptor for activated C-kinase (RACK1) as a novel interaction partner of BMPRII by yeast 2-hybrid analyses using the kinase domain of BMPRII as a bait. Glutathione-S-transferase pull-down and coimmunoprecipitation confirmed the interaction of RACK1 with BMPRII in vitro and in vivo. RACK1–BMPRII interaction was reduced when kinase domain mutations occurring in patients with PAH were introduced to BMPRII. Immunohistochemistry of lung sections from PAH and control patients and immunofluorescence analysis of primary pulmonary arterial smooth muscle cells demonstrated colocalization of BMPRII and RACK1 in vivo. Quantitative reverse-transcription polymerase chain reaction and Western blot analysis showed significant downregulation of RACK1 expression in the rat model of monocrotaline-induced PAH but not in pulmonary arterial smooth muscle cells from PAH patients. Abrogation of RACK1 expression in pulmonary arterial smooth muscle cells led to decreased Smad1 phosphorylation and increased proliferation, whereas overexpression of RACK1 led to increased Smad1 phosphorylation and decreased proliferation.

Conclusions— RACK1, a novel interaction partner of BMPRII, constitutes a new negative regulator of pulmonary arterial smooth muscle cell proliferation, suggesting a potential role for RACK1 in the pathogenesis of PAH.

---

 

CLINICAL PERSPECTIVE

This article has been cited by other articles:

				R. D. Machado, O. Eickelberg, C. G. Elliott, M. W. Geraci, M. Hanaoka, J. E. Loyd, J. H. Newman, J. A. Phillips III, F. Soubrier, R. C. Trembath, et al. Genetics and genomics of pulmonary arterial hypertension. J. Am. Coll. Cardiol., June 30, 2009; 54(1 Suppl): S32 - S42. [Abstract] [Full Text] [PDF]

				A. Zierer, S. J. Melby, R. K. Voeller, and M. R. Moon Interatrial shunt for chronic pulmonary hypertension: differential impact of low-flow vs. high-flow shunting Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H639 - H644. [Abstract] [Full Text] [PDF]

				E. Papakonstantinou, F. M. Kouri, G. Karakiulakis, I. Klagas, and O. Eickelberg Increased hyaluronic acid content in idiopathic pulmonary arterial hypertension Eur. Respir. J., December 1, 2008; 32(6): 1504 - 1512. [Abstract] [Full Text] [PDF]

				J. West, J. Harral, K. Lane, Y. Deng, B. Ickes, D. Crona, S. Albu, D. Stewart, and K. Fagan Mice expressing BMPR2R899X transgene in smooth muscle develop pulmonary vascular lesions Am J Physiol Lung Cell Mol Physiol, November 1, 2008; 295(5): L744 - L755. [Abstract] [Full Text] [PDF]

				G. Kwapiszewska, M. Wygrecka, L. M. Marsh, S. Schmitt, R. Trosser, J. Wilhelm, K. Helmus, B. Eul, A. Zakrzewicz, H. A. Ghofrani, et al. Fhl-1, a New Key Protein in Pulmonary Hypertension Circulation, September 9, 2008; 118(11): 1183 - 1194. [Abstract] [Full Text] [PDF]

				K.-H. Hong, Y. J. Lee, E. Lee, S. O. Park, C. Han, H. Beppu, E. Li, M. K. Raizada, K. D. Bloch, and S. P. Oh Genetic Ablation of the Bmpr2 Gene in Pulmonary Endothelium Is Sufficient to Predispose to Pulmonary Arterial Hypertension Circulation, August 12, 2008; 118(7): 722 - 730. [Abstract] [Full Text] [PDF]

				P. B. Yu, D. Y. Deng, H. Beppu, C. C. Hong, C. Lai, S. A. Hoyng, N. Kawai, and K. D. Bloch Bone Morphogenetic Protein (BMP) Type II Receptor Is Required for BMP-mediated Growth Arrest and Differentiation in Pulmonary Artery Smooth Muscle Cells J. Biol. Chem., February 15, 2008; 283(7): 3877 - 3888. [Abstract] [Full Text] [PDF]